Patents by Inventor Guozhong YE

Guozhong YE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240083873
    Abstract: Disclosed are a pyrimidine carboxamide compound and an application thereof. Further provided are a pyrimidine carboxamide compound represented by formula (I), or a tautomer, mesomer, racemate, enantiomer, or diastereomer thereof, a mixture form thereof, or a pharmaceutically acceptable salt thereof. The compound can be used as a Vanin enzyme inhibitor, and can be used to prepare a drug for treating various diseases, including Crohn's disease, ulcerative colitis, and so on.
    Type: Application
    Filed: November 3, 2021
    Publication date: March 14, 2024
    Inventors: Yuanshan Yao, Guozhong Ye, Linbo Luan, Yongkai Chen, Chaodong Wang
  • Publication number: 20230250064
    Abstract: A one-pot method is used to prepare a fused pyrazole-type compound substituted at nitrogen on 2-position, specifically an indazole-type compound substituted at nitrogen on 2-position. In the method, after azidizing a halogen in a substrate, without post-processing, R-NH2 can be directly added to proceed a ring-closing reaction with an aldehyde group, so as to give the fused pyrazole-type compound substituted at nitrogen on 2-position. For example, by using 2-fluoro-4 methoxy-5-nitro benzaldehyde as a raw material, the indazole-type compound substituted at nitrogen on 2-position can be obtained via azidation and ring-closing steps, and then a series of indazole derivatives can be produced by means of a hydrogenation reaction and a condensation reaction.
    Type: Application
    Filed: June 18, 2021
    Publication date: August 10, 2023
    Inventors: Guozhong YE, Yong TIAN, Shikang FU, Zongguo SUN, Yongkai CHEN, Chaodong WANG
  • Publication number: 20220298139
    Abstract: A compound represented by formula I are provided. The stereoisomer, racemate, tautomer, isotopic label, prodrug or a pharmaceutically acceptable salt of the compound, and a pharmaceutical composition containing the compound, a preparation method, and medical use of the compound are further provided. The structure is as shown in formula I.
    Type: Application
    Filed: September 23, 2020
    Publication date: September 22, 2022
    Inventors: Guozhong YE, Chenli DING, Yawen DING, Qian HE, Chaodong WANG
  • Publication number: 20220204473
    Abstract: The present disclosure relates a compound as an IRAK inhibitor. Specifically, the present disclosure provides a compound of formula I, or a cis-trans isomer, an optical isomer, a racemate, a pharmaceutically acceptable salt, a prodrug, a deuterated derivative thereof, a hydrate or a solvate thereof. The compounds disclosed herein have potent inhibitory effects on IRAK and thus have therapeutic effect on IRAK-related diseases.
    Type: Application
    Filed: December 25, 2019
    Publication date: June 30, 2022
    Inventors: Yan FENG, Guozhong YE, Shiqiang LI, Zhilong HU, Chaodong WANG